Mesothelioma News

Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
The early detection test will mainly target over 45 million Americans who are at an increased risk of lung cancer due to smoking, as well […]

BLOOMFIELD, N.J., April 18, 2007 /PRNewswire-FirstCall/ — ONCONASE (ranpirnase), Alfacell Corporation’s lead drug candidate, may have potential as a chemopreventive agent, according to world-renowned mesothelioma researcher Michele Carbone M.D., Ph.D., at this week’s American Association for Cancer Research (AACR) Annual Meeting.
In a series of poster presentations, Dr. Carbone highlighted the growing worldwide problem of asbestos […]

DETROIT, April 17 /PRNewswire/ — The Barbara Ann Karmanos Cancer
Institute today announced significant scientific findings that could lead
to better treatment and therapies for cancer patients suffering from
malignant pleural mesothelioma.
Karmanos scientists presented their research at the American
Association of Cancer Research (AACR) annual meeting in Los Angeles, CA.
“We are getting closer and closer to making an impact […]

Suberoylanilide Hydroxamic Acid (SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
This study is currently recruiting patients.Verified by Merck April 2007

Sponsored by:
Merck

Information provided by:
Merck

ClinicalTrials.gov Identifier:
NCT00128102

Purpose

This is […]

If you worked at one of the old vermiculite ore processing plants in downtown Salt Lake City, call the Utah Department of Health at 538-6191. Your life may depend on it.
    And while you’re on the phone, tell them “Thanks a lot.” Say it sarcastically.
    The health department has known for at least six years […]

By Jeremy Small

A GROUP offering support to sufferers of asbestos exposure in York has condemned a decision to block the NHS dispensing a drug to treat the condition.
A document published by the National Institute For Clinical Excellence (NICE) - which provides guidance on treating ill-health - said it did not recommend pemetrexed disodium (Alimta) as […]

Woman who has rare illness fears for friends from teenage years

[…]

Study targets rates near former vermiculite sites

By Lois M. CollinsDeseret Morning News

      A Department of Health study found no increased rate of asbestos-associated cancer among those living within a two-mile radius of two former vermiculite plants in downtown Salt Lake City. And although the study found significantly […]